Friedman Y, Lang M, Burke G
Endocr Res Commun. 1978;5(2):109-24. doi: 10.3109/07435807809089012.
Bovine thyroid cyclic AMP-dependent protein kinase was purified by DEAE-Sephadex and Sephadex G-200 chromatography. This preparation showed a 240-fold increase in specific activity over the initial 20,000 x g supernatant with histone as substrate and 1 micronM cyclic AMP in the assay mixture. In the presence of 2.5 X 10(-5)M L-triiodothyronine (T3), protein kinase activity was significantly reduced; 50% inhibition was achieved at 1 X 10(-4) M. Tests of diverse thyroid hormone analogs showed that T3 and its derivatives were more potent inhibitors than T4 and its derivatives which, in turn, were more potent than thyronine or diiodothyronine. Mono- and diiodotyrosine, tyrosine, and iodide were without effect. Triiodothyronine did not inhibit kidney, spleen, or lung protein kinase activity. The magnitude of the inhibition was the same whether or not cyclic AMP (1 micronM) was present in the incubation mixture, suggesting an effect on the catalytic, rather than the regulatory subunit of the enzyme. The inhibition of protein kinase by thyroid hormone was not influenced by Mg++ concentration but was overcome in a competitive manner by increasing ATP concentration. Increasing the histone concentration did not modify the inhibition. Although these studies suggest a novel cellular control mechanism, the high thyroid hormone concentrations required and the lack of concordance between inhibitory effects and biologic activity of the analogs tested precludes assumption of physiologic relevance.
通过DEAE-葡聚糖凝胶和葡聚糖凝胶G-200柱色谱法纯化牛甲状腺环磷酸腺苷依赖性蛋白激酶。以组蛋白为底物且在测定混合物中含有1微摩尔环磷酸腺苷时,该制剂的比活性相较于最初的20,000×g上清液增加了240倍。在存在2.5×10⁻⁵M L-三碘甲状腺原氨酸(T3)的情况下,蛋白激酶活性显著降低;在1×10⁻⁴M时实现了50%的抑制。对多种甲状腺激素类似物的测试表明,T3及其衍生物是比T4及其衍生物更强效的抑制剂,而T4及其衍生物又比甲状腺素或二碘甲状腺原氨酸更强效。单碘酪氨酸、二碘酪氨酸、酪氨酸和碘化物没有作用。三碘甲状腺原氨酸不抑制肾脏、脾脏或肺的蛋白激酶活性。无论温育混合物中是否存在环磷酸腺苷(1微摩尔),抑制程度都是相同的,这表明是对酶的催化亚基而非调节亚基产生作用。甲状腺激素对蛋白激酶的抑制不受镁离子浓度的影响,但通过增加ATP浓度可竞争性地克服这种抑制。增加组蛋白浓度不会改变抑制作用。尽管这些研究提示了一种新的细胞控制机制,但所需的高甲状腺激素浓度以及所测试类似物的抑制作用与生物活性之间缺乏一致性,使得无法假定其具有生理相关性。